9.14
price up icon0.22%   0.02
 
loading
Mimedx Group Inc stock is traded at $9.14, with a volume of 417.21K. It is up +0.22% in the last 24 hours and up +0.44% over the past month. MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
See More
Previous Close:
$9.12
Open:
$9.22
24h Volume:
417.21K
Relative Volume:
0.54
Market Cap:
$1.34B
Revenue:
$340.46M
Net Income/Loss:
$98.11M
P/E Ratio:
14.64
EPS:
0.6245
Net Cash Flow:
$43.17M
1W Performance:
+6.16%
1M Performance:
+0.44%
6M Performance:
+27.65%
1Y Performance:
+12.29%
1-Day Range:
Value
$9.085
$9.362
1-Week Range:
Value
$8.58
$9.362
52-Week Range:
Value
$5.47
$10.14

Mimedx Group Inc Stock (MDXG) Company Profile

Name
Name
Mimedx Group Inc
Name
Phone
(770) 651-9100
Name
Address
1775 W OAK COMMONS COURT, NE, MARIETTA
Name
Employee
895
Name
Twitter
Name
Next Earnings Date
2024-10-30
Name
Latest SEC Filings
Name
MDXG's Discussions on Twitter

Compare MDXG with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
6.49 0 0 0 0 0.00
 icon
PSNYW
Polestar Automotive Holding Uk
0.2299 485.17M 2.07B -1.42B -1.37B -0.6765
 icon
GOODO
Gladstone Commercial Corporation
21.16 372.90M 0 0 0 0.00
 icon
MOBBW
Mobilicom Limited Warrants
0.3236 278.60M 0 0 0 0.00
 icon
SHMD
Schmid Group N V
2.40 103.35M 0 0 0 0.00
 icon
JUNE
Dhandho Junoon Etf
3.72 48.39M 0 0 0 0.00

Mimedx Group Inc Stock (MDXG) Upgrades & Downgrades

Date Action Analyst Rating Change
Jul-02-24 Initiated Cantor Fitzgerald Overweight
Mar-07-24 Initiated Lake Street Buy
Oct-27-23 Initiated Craig Hallum Buy
Oct-13-22 Initiated Mizuho Buy
Jul-26-21 Initiated Northland Capital Outperform
Mar-19-21 Initiated H.C. Wainwright Buy
View All

Mimedx Group Inc Stock (MDXG) Latest News

pulisher
Jan 17, 2025

MiMedx Group Updates Investor Presentation in Recent 8-K Filing - Defense World

Jan 17, 2025
pulisher
Jan 16, 2025

Learn to Evaluate (MDXG) using the Charts - Stock Traders Daily

Jan 16, 2025
pulisher
Jan 13, 2025

Barclays PLC Buys 163,005 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World

Jan 13, 2025
pulisher
Jan 13, 2025

Barclays PLC Purchases 163,005 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat

Jan 13, 2025
pulisher
Jan 07, 2025

Tendonitis Pipeline Insights 2024: Therapies, Clinical Trials, MOA, ROA, and Developments | MetrioPharm, MiMedX group, InGeneron, Novartis, R3 Stem Cell - Barchart

Jan 07, 2025
pulisher
Jan 07, 2025

MiMedx Group, Inc.'s (NASDAQ:MDXG) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - Simply Wall St

Jan 07, 2025
pulisher
Jan 07, 2025

Principal Financial Group Inc. Purchases 3,292 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World

Jan 07, 2025
pulisher
Jan 05, 2025

(MDXG) Trading Report - Stock Traders Daily

Jan 05, 2025
pulisher
Jan 04, 2025

MiMedx Group, Inc. (NASDAQ:MDXG) Receives $12.00 Consensus Target Price from Analysts - Defense World

Jan 04, 2025
pulisher
Jan 01, 2025

MiMedx Group, Inc. (NASDAQ:MDXG) Given Average Recommendation of "Buy" by Analysts - MarketBeat

Jan 01, 2025
pulisher
Dec 30, 2024

MiMedx Group, Inc. (NASDAQ:MDXG) Shares Bought by Geode Capital Management LLC - Defense World

Dec 30, 2024
pulisher
Dec 30, 2024

Northland Capmk Predicts MiMedx Group Q1 Earnings - MarketBeat

Dec 30, 2024
pulisher
Dec 30, 2024

Northland Capmk Forecasts MiMedx Group Q1 Earnings - Defense World

Dec 30, 2024
pulisher
Dec 29, 2024

MiMedx Group, Inc. (NASDAQ:MDXG) Shares Acquired by Barclays PLC - Defense World

Dec 29, 2024
pulisher
Dec 29, 2024

Barclays PLC Has $1.55 Million Stake in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat

Dec 29, 2024
pulisher
Dec 26, 2024

How the (MDXG) price action is used to our Advantage - Stock Traders Daily

Dec 26, 2024
pulisher
Dec 26, 2024

Jane Street Group LLC Grows Position in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat

Dec 26, 2024
pulisher
Dec 26, 2024

MiMedx Group, Inc. (NASDAQ:MDXG) Shares Acquired by Jane Street Group LLC - Defense World

Dec 26, 2024
pulisher
Dec 23, 2024

We Think MiMedx Group (NASDAQ:MDXG) Can Manage Its Debt With Ease - Simply Wall St

Dec 23, 2024
pulisher
Dec 23, 2024

State Street Corp Lowers Position in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World

Dec 23, 2024
pulisher
Dec 23, 2024

State Street Corp Has $22.81 Million Stock Position in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat

Dec 23, 2024
pulisher
Dec 21, 2024

MiMedx Group, Inc. (NASDAQ:MDXG) Shares Bought by Fmr LLC - Defense World

Dec 21, 2024
pulisher
Dec 19, 2024

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 33,241 Shares of MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World

Dec 19, 2024
pulisher
Dec 18, 2024

MIMEDX Group's SWOT analysis: wound care firm's stock faces market headwinds - Investing.com

Dec 18, 2024
pulisher
Dec 17, 2024

MIMEDX Files Patent Infringement Lawsuit Against Surgenex - GlobeNewswire

Dec 17, 2024
pulisher
Dec 17, 2024

MiMedx Group (MDXG) Files Patent Infringement Lawsuit Against Surgenex - StreetInsider.com

Dec 17, 2024
pulisher
Dec 17, 2024

MIMEDX Battles Patent Infringement: Files Major Lawsuit Over Placental Allograft Technology - StockTitan

Dec 17, 2024
pulisher
Dec 16, 2024

MiMedx extends corporate HQ lease, ensures director indemnification - Investing.com

Dec 16, 2024
pulisher
Dec 16, 2024

MiMedx extends corporate HQ lease, ensures director indemnification By Investing.com - Investing.com UK

Dec 16, 2024
pulisher
Dec 16, 2024

The Manufacturers Life Insurance Company Raises Position in MiMedx Group, Inc. (NASDAQ:MDXG) - Defense World

Dec 16, 2024
pulisher
Dec 15, 2024

(MDXG) On The My Stocks Page - Stock Traders Daily

Dec 15, 2024
pulisher
Dec 14, 2024

EX-MiMEDX EMPLOYEES ALLEGE MiMEDX "PRESSURE[D] HEALTHCARE PROVIDERS TO TREAT WOUNDED VETERANS, DIABETICS, CHRONIC WOUND SUFFERERS, AND OTHER PATIENTS WITH MEDICALLY UNNECESSARY OR UNSUITABLE P - The Eastern Progress Online

Dec 14, 2024
pulisher
Dec 12, 2024

MIMEDX Group's SWOT analysis: wound care firm's stock faces growth hurdles - Investing.com Nigeria

Dec 12, 2024
pulisher
Dec 11, 2024

MiMedx Group, Inc. (NASDAQ:MDXG) Stock Holdings Lifted by Charles Schwab Investment Management Inc. - MarketBeat

Dec 11, 2024
pulisher
Dec 09, 2024

Amniotic Membrane Market Expected to Reach Huge Growth by 2031 | - openPR

Dec 09, 2024
pulisher
Dec 07, 2024

MiMedx Group (NASDAQ:MDXG) shareholder returns have been decent, earning 39% in 3 years - Simply Wall St

Dec 07, 2024
pulisher
Dec 07, 2024

Brokerages Set MiMedx Group, Inc. (NASDAQ:MDXG) PT at $12.00 - MarketBeat

Dec 07, 2024
pulisher
Dec 05, 2024

MDXG stock soars to 52-week high, touches $9.66 By Investing.com - Investing.com South Africa

Dec 05, 2024
pulisher
Dec 04, 2024

MDXG stock soars to 52-week high, touches $9.66 - Investing.com India

Dec 04, 2024
pulisher
Dec 04, 2024

MIMEDX to Participate in Upcoming Investor Conferences - GlobeNewswire

Dec 04, 2024
pulisher
Dec 04, 2024

MIMEDX to Present at Three Major Healthcare Investor Conferences in December - StockTitan

Dec 04, 2024
pulisher
Dec 02, 2024

Institutional investors own a significant stake of 43% in MiMedx Group, Inc. (NASDAQ:MDXG) - Yahoo Finance

Dec 02, 2024
pulisher
Nov 30, 2024

MiMedx Group Q3 2024 Earnings Preview - MSN

Nov 30, 2024
pulisher
Nov 29, 2024

Isthmus Partners LLC Trims Holdings in MiMedx Group, Inc. (NASDAQ:MDXG) - MarketBeat

Nov 29, 2024
pulisher
Nov 28, 2024

MiMedx Group Stock Soars to 52-Week High of $9.62 By Investing.com - Investing.com South Africa

Nov 28, 2024

Mimedx Group Inc Stock (MDXG) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$21.80
price up icon 4.81%
$73.47
price up icon 2.14%
$22.10
price up icon 16.13%
$367.97
price up icon 2.52%
biotechnology ONC
$218.70
price up icon 4.10%
$117.25
price up icon 4.75%
Cap:     |  Volume (24h):